BIOXCEL THERAPEUTICS INC (BTAI)

US09075P1057 - Common Stock

2.54  +0.02 (+0.79%)

After market: 2.54 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.38M380.00K0.000.000.00
Cost Of Goods
1.26M20.00KN/AN/AN/A
Gross Profit
120.00K360.00KN/AN/AN/A
Operating Expenses
167.74M160.00M106.94M82.30M33.60M
Research and Development
84.33M91.24M52.71M58.00M25.80M
Selling, General, and Administrative Expenses
83.41M68.76M54.23M24.30M7.80M
Operating Income
-167.62M-159.65M-106.94M-82.30M-33.60M
Interest Income/Expense
-7.67M-5.69M0.00130.00K630.00K
Other Income/Expense
394.00K-430.00KN/AN/AN/A
Non Recurring Items
-4.16MN/AN/AN/AN/A
Income Before Taxes
-179.05M-165.76M-106.93M-82.17M-32.97M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-179.05M-165.76M-106.93M-82.17M-32.97M
EBITDA
-167.30M-159.32M-106.64M-82.11M-33.44M
 
Per Share Data
EPS Diluted Total Ops
-6.15-5.92-4.05-3.79-2.02
Non GAAP EPS
-6.15-5.91-4.08-3.79-2.02
 
Statistics
Gross Profit Margin
8.70%94.74%N/AN/AN/A
Profit Margin
-12974.86%-43621.05%N/AN/AN/A
Operating Profit Margin
-12146.30%-42013.16%N/AN/AN/A

All data in USD

Charts